01—History
Long-Term Debt History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $546.8M
1 older move runs past ±150% (largest +469.7%); point at, tap or drag across the bars to read one.
02—Ledger
Long-Term Debt, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $546.8M | −51.3% | 10-K | |
| FY2024 | $1.12B | −4.7% | 10-K | |
| FY2023 | $1.18B | +2.0% | 10-K | |
| FY2022 | $1.15B | +44.3% | 10-K | |
| FY2021 | $800.0M | +124.5% | 10-K | |
| FY2020 | $356.3M | +6.1% | 10-K | |
| FY2019 | $335.9M | +6.1% | 10-K | |
| FY2018 | $316.6M | +469.7% | 10-K | |
| FY2017 | $55.6M | +1.4% | 10-K | |
| FY2016 | $54.8M | +148.7% | 10-K | |
| FY2015 | $22.0M | −11.4% | 10-K | |
| FY2014 | $24.9M | +52.1% | 10-K | |
| FY2013 | $16.3M | +0.7% | 10-K | |
| FY2012 | $16.2M | — | 10-K | |
| FY2011 | $0 | — | 10-K |
03—Questions
What is long-term debt?
Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.
What is Insmed's current long-term debt?
Insmed (INSM) annual long-term debt for 2025 was $546.8M, a 51.25% decline from 2024. Insmed long-term debt for the quarter ending September 30, 2026 was $546.8M.
What was Insmed's long-term debt in 2024?
Insmed annual long-term debt for 2024 was $1.12B, a 4.74% decline from 2023.
What was Insmed's long-term debt in 2023?
Insmed annual long-term debt for 2023 was $1.18B, a 2.03% increase from 2022.
What is Insmed's 5-year long-term debt CAGR?
Insmed long-term debt grew at a compound annual growth rate (CAGR) of 8.94% from FY2020 to FY2025, going from $356.3M to $546.8M over 5 years.
- Company
- Insmed
- Ticker
- INSM
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations